These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35819729)

  • 1. Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer.
    Sun J; Wang F; Zhou H; Zhao C; Li K; Fan C; Wang J
    Discov Oncol; 2022 Jul; 13(1):63. PubMed ID: 35819729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients.
    Sun Y; Long H; Sun L; Sun X; Pang L; Chen J; Yi Q; Liang T; Shen Y
    Cancer Cell Int; 2019; 19():253. PubMed ID: 31582909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of long noncoding RNA PGM5-AS1 correlates with tumor progression and predicts poor prognosis in clear cell renal cell carcinoma.
    Qian M; Zheng JL; Kang N; Su YL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10685-10690. PubMed ID: 31858536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer.
    Du L; Gao Y
    J Transl Med; 2021 Jan; 19(1):12. PubMed ID: 33407592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Downregulation of lncRNA
    Shen Y; Qi L; Li Y; Zhang Y; Gao X; Zhu Y; Wang K
    Cancer Biother Radiopharm; 2021 Mar; 36(2):220-229. PubMed ID: 32354224
    [No Abstract]   [Full Text] [Related]  

  • 6. miR-1224-3p Promotes Breast Cancer Cell Proliferation and Migration through PGM5-Mediated Aerobic Glycolysis.
    Ran F; Zhang Y; Shi Y; Liu J; Li H; Ding L; Ye Q
    J Oncol; 2021; 2021():5529770. PubMed ID: 33986801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs PGM5-AS1 upregulates Decorin (DCN) to inhibit cervical cancer progression by sponging miR-4284.
    Wang H; Wang D; Wei Q; Li C; Li C; Yang J
    Bioengineered; 2022 Apr; 13(4):9872-9884. PubMed ID: 35420507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGM5: a novel diagnostic and prognostic biomarker for liver cancer.
    Jiao Y; Li Y; Jiang P; Han W; Liu Y
    PeerJ; 2019; 7():e7070. PubMed ID: 31218127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-induced long non-coding RNA PGM5-AS1 inhibits the progression of esophageal squamous cell carcinoma through regulating miR-466/PTEN axis.
    Zhihua Z; Weiwei W; Lihua N; Jianying Z; Jiang G
    IUBMB Life; 2019 Oct; 71(10):1492-1502. PubMed ID: 31185143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
    Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
    Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codonopsis pilosula polysaccharide alleviates rotenone-induced murine brain organoids death through downregulation of gene body DNA methylation modification in the ZIC4/PGM5/CAMTA1 axis.
    Chen H; Wen Y; Yu Z; Du X; Pan W; Liu T
    Biochem Biophys Rep; 2024 Mar; 37():101593. PubMed ID: 38074999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-1293 acts as a tumor promotor in lung adenocarcinoma
    Chen B; Zheng S; Jiang F
    PeerJ; 2021; 9():e12140. PubMed ID: 34616611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced long noncoding RNA PGM5-AS1 facilitated proliferation and invasion of colorectal cancer through sponging miR-100-5p.
    Zhou B; Yi F; Chen Y; Li CH; Cheng YS; Yang K
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7972-7981. PubMed ID: 32767323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
    Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
    Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
    García-Cruz E; Piqueras M; Huguet J; Peri L; Izquierdo L; Musquera M; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
    BJU Int; 2012 Dec; 110(11 Pt B):E541-6. PubMed ID: 22584031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer.
    Hui B; Lu C; Wang J; Xu Y; Yang Y; Ji H; Li X; Xu L; Wang J; Tang W; Wang K; Gu Y
    J Cell Physiol; 2022 Jan; 237(1):911-933. PubMed ID: 34463962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
    Guo J; Wang M; Wang Z; Liu X
    PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the effect of PGM on survival prognosis of tumor patients.
    Zheng Z; Bai J; Shen S; Zhu C; Zhou Y; Zhang X
    Front Oncol; 2022; 12():1060372. PubMed ID: 36544711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Random forest-based modelling to detect biomarkers for prostate cancer progression.
    Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
    Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.